| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1005228311 |
| P356 | DOI | 10.2165/11317010-000000000-00000 |
| P698 | PubMed publication ID | 19719333 |
| P5875 | ResearchGate publication ID | 26779082 |
| P50 | author | Edzard Ernst | Q70166 |
| Angelo A. Izzo | Q42411084 | ||
| P2860 | cites work | St John's wort for major depression | Q24241294 |
| Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide | Q24651117 | ||
| Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics | Q24656624 | ||
| Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects | Q24678775 | ||
| Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females | Q24679237 | ||
| Comparison between swallowing and chewing of garlic on levels of serum lipids, cyclosporine, creatinine and lipid peroxidation in renal transplant recipients. | Q24815942 | ||
| Herb-drug interactions: a literature review | Q28176037 | ||
| Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers | Q28190298 | ||
| Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction | Q28213939 | ||
| The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo | Q28241382 | ||
| Herb-drug interactions in oncology: focus on mechanisms of induction | Q28255139 | ||
| Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba | Q28344326 | ||
| Herb-drug interactions: review and assessment of report reliability | Q28365912 | ||
| Herbal medicines as a factor in delirium | Q28369070 | ||
| Interactions between herbal medicines and prescribed drugs: a systematic review | Q30790065 | ||
| Effects of St. John's wort on irinotecan metabolism | Q33184162 | ||
| Herbal and dietary supplement--drug interactions in patients with chronic illnesses. | Q33317576 | ||
| Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. | Q33392243 | ||
| Kava and dopamine antagonism | Q33734168 | ||
| St John's wort: Prozac from the plant kingdom. | Q33950220 | ||
| The effect of garlic supplements on the pharmacokinetics of saquinavir | Q33956369 | ||
| Herbal medicines and perioperative care | Q34083672 | ||
| Multiple-Dose Administration of Ginkgo biloba Did Not Affect Cytochrome P-450 2D6 or 3A4 Activity in Normal Volunteers | Q34277542 | ||
| Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence | Q34309286 | ||
| In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes | Q34419646 | ||
| Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation | Q34421963 | ||
| Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.). | Q34484334 | ||
| Garlic interaction with fluindione: a case report. | Q44696317 | ||
| Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers | Q44697441 | ||
| Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers | Q44697443 | ||
| St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole | Q44787217 | ||
| St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism | Q44827285 | ||
| The influence of St John's Wort on CYP2C19 activity with respect to genotype | Q44897883 | ||
| Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin | Q44923001 | ||
| Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial | Q44967299 | ||
| Induction of imatinib metabolism by hypericum perforatum | Q45007465 | ||
| Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers | Q45062240 | ||
| Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction. | Q45095090 | ||
| In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. | Q45146006 | ||
| The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate | Q45146720 | ||
| Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers | Q45171973 | ||
| Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole | Q45193955 | ||
| Serotonin syndrome resulting from an herbal detox cocktail | Q45235359 | ||
| CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations | Q45259361 | ||
| Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis | Q46231784 | ||
| St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive | Q46240940 | ||
| Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial | Q46371414 | ||
| No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract | Q46459610 | ||
| Interaction between warfarin and Panax ginseng in ischemic stroke patients | Q46475692 | ||
| Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding | Q46507921 | ||
| St. John's Wort, corticosteroids, cocaine, alcohol ... and a first manic episode | Q46587528 | ||
| Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics | Q46589222 | ||
| Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction? | Q46657916 | ||
| Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel | Q46774278 | ||
| The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. | Q46845808 | ||
| Fatal seizures due to potential herb-drug interactions with Ginkgo biloba | Q46898710 | ||
| Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo | Q46905661 | ||
| Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate | Q46908034 | ||
| Lack of pharmacokinetic interaction between St. John's wort and prednisone | Q46958985 | ||
| Association between priapism and concurrent use of risperidone and Ginkgo biloba | Q46972442 | ||
| Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). | Q47775763 | ||
| Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo | Q48598672 | ||
| Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers | Q48651682 | ||
| Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients | Q48686546 | ||
| St. John's wort and antidepressant drug interactions in the elderly | Q48749332 | ||
| Delayed emergence and St. John's wort. | Q49137471 | ||
| Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. | Q50184418 | ||
| Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial | Q50237753 | ||
| Herbal medicines and postoperative haemorrhage. | Q51221712 | ||
| A possible cause of cardiovascular collapse during anesthesia: long-term use of St. John's Wort. | Q51365200 | ||
| Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. | Q51465582 | ||
| Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. | Q52968365 | ||
| Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline. | Q53781790 | ||
| Impact of ginkgo biloba on the pharmacokinetics of digoxin. | Q53859229 | ||
| Indinavir concentrations and St John's wort. | Q55033637 | ||
| Interaction between curry ingredient (karela) and drug (chlorpropamide) | Q66702306 | ||
| Bees, ginseng and MAOIs revisited | Q68002127 | ||
| Interaction of ginseng with phenelzine | Q69061821 | ||
| Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme | Q37161542 | ||
| Potential of pharmacokinetic profiling for detecting herbal interactions with drugs | Q37163340 | ||
| In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? | Q37212905 | ||
| A critical evaluation of drug interactions with Echinacea spp. | Q37212909 | ||
| Clinical drugs that interact with St. John's wort and implication in drug development | Q37232852 | ||
| Serenoa repens (saw palmetto): a systematic review of adverse events | Q37547218 | ||
| Back to basics. | Q40477719 | ||
| Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects | Q41123941 | ||
| Herbal medicines: can we do without pharmacologist? | Q42003490 | ||
| Drug interaction between St John's Wort and quazepam. | Q42158860 | ||
| Coma from the health food store: interaction between kava and alprazolam | Q42551855 | ||
| Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial | Q42598774 | ||
| Effect of St John's wort on imatinib mesylate pharmacokinetics | Q42637650 | ||
| Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception | Q42760300 | ||
| Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort | Q42958186 | ||
| Drug interaction between St John's wort and nevirapine | Q43556089 | ||
| St. John's wort: effect on CYP2D6 activity using dextromethorphan-dextrorphan ratios | Q43761157 | ||
| The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity | Q43775254 | ||
| Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin | Q43830741 | ||
| Ginko, Vioxx and excessive bleeding--possible drug-herb interactions: case report | Q43858589 | ||
| Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ). | Q43859427 | ||
| Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort | Q43940399 | ||
| Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury | Q43959255 | ||
| Effect of St John's wort on the pharmacokinetics of fexofenadine | Q44043537 | ||
| Phenelzine and the dream machine--ramblings and reflections. | Q44073363 | ||
| Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans | Q44139044 | ||
| Possible serotonin syndrome after combination of buspirone and St John's Wort | Q44263574 | ||
| Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects | Q44289523 | ||
| Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients | Q44362349 | ||
| Methadone maintenance treatment and St. John's Wort - a case report | Q44370716 | ||
| Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen | Q44485571 | ||
| Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers | Q44532788 | ||
| Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme | Q44586531 | ||
| The interaction between St John's wort and an oral contraceptive | Q44685310 | ||
| Hyperforin in St. John's wort drug interactions | Q34494412 | ||
| St John's Wort supplements endanger the success of organ transplantation | Q34558766 | ||
| Complementary medicines in psychiatry: review of effectiveness and safety | Q34564616 | ||
| Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum | Q34583010 | ||
| Garlic (Allium sativum L.): adverse effects and drug interactions in humans | Q34698908 | ||
| Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? | Q34739887 | ||
| No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers. | Q34819036 | ||
| St. John's wort and oral contraceptives: reasons for concern? | Q35026875 | ||
| Panax ginseng. | Q35574823 | ||
| Drug interactions between herbal and prescription medicines. | Q35593896 | ||
| Interaction of St John's wort with conventional drugs: systematic review of clinical trials | Q35615173 | ||
| Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba | Q35765836 | ||
| Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans | Q35781981 | ||
| Interaction of St John's wort with low‐dose oral contraceptive therapy: a randomized controlled trial | Q35825530 | ||
| Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects | Q35826093 | ||
| Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers | Q35846696 | ||
| Drug interactions with St John's wort : mechanisms and clinical implications | Q35879020 | ||
| Adverse effects of St. John's Wort: a systematic review | Q35956630 | ||
| Herb-drug interactions: an overview of the clinical evidence | Q36014951 | ||
| Clinical risk management of herb-drug interactions | Q36025053 | ||
| Interactions between herbal and conventional medicines | Q36082038 | ||
| Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents | Q36551135 | ||
| Development of quantitative structure-activity relationships and its application in rational drug design | Q36683643 | ||
| The recovery time-course of CYP3A after induction by St John's wort administration | Q36729151 | ||
| Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. | Q36779045 | ||
| Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center | Q36840598 | ||
| Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects | Q36842490 | ||
| A detailed safety assessment of a saw palmetto extract | Q36843661 | ||
| Identification of drugs that interact with herbs in drug development. | Q36913494 | ||
| Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. | Q36926307 | ||
| Patient Disclosure about Herb and Supplement Use among Adults in the US. | Q36981134 | ||
| Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring | Q37016989 | ||
| The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature | Q37036593 | ||
| Effect of Ginkgo biloba extract on microsomal enzyme induction | Q69651450 | ||
| The effect of garlic extract on human metabolism of acetaminophen | Q72104641 | ||
| Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) | Q73145709 | ||
| Probable interaction between warfarin and ginseng | Q73166583 | ||
| Spontaneous hyphema associated with ingestion of Ginkgo biloba extract | Q73199998 | ||
| Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450 | Q73201582 | ||
| Drug interaction of herbal tea containing St. John's wort with cyclosporine | Q73218902 | ||
| Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation | Q73246112 | ||
| St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 | Q73443725 | ||
| Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers | Q73443729 | ||
| Acute heart transplant rejection due to Saint John's wort | Q73465831 | ||
| Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers | Q73501072 | ||
| Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum) | Q73893153 | ||
| Drug interaction of St John's wort with cyclosporin | Q73923310 | ||
| [St. Johns wort-venlafaxine interaction] | Q74100379 | ||
| Unexplained decrease of cyclosporin trough levels in a compliant renal transplant patient | Q74291281 | ||
| Drug interaction between St. John's wort and cyclosporine | Q74299422 | ||
| SSRIs and St.John's Wort: possible toxicity? | Q74368781 | ||
| [St. John's wort: interaction with cyclosporine increases risk of rejection for the kidney transplant and raises daily cost of medication] | Q74521003 | ||
| Association of Ginkgo biloba with intracerebral hemorrhage | Q74673650 | ||
| St John's wort: a hidden risk for transplant patients | Q77708483 | ||
| Potential metabolic interaction between St. John's wort and theophylline | Q77761677 | ||
| Hypericum perforatum (St John's wort) in depression: pest or blessing? | Q77793078 | ||
| Herbal medicine: the dangers of drug interaction | Q78365884 | ||
| Potential drug-herb interaction with antiplatelet/anticoagulant drugs | Q79214582 | ||
| Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol | Q80058660 | ||
| Brief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women | Q80186135 | ||
| Herb-drug interactions. St. John's wort and prescription medications | Q80387628 | ||
| Herb-drug interactions | Q81133365 | ||
| Aged garlic extract may be safe for patients on warfarin therapy | Q82582261 | ||
| Safety of St John's wort (Hypericum perforatum) | Q93929858 | ||
| Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects | Q94681842 | ||
| Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients | Q94702263 | ||
| P433 | issue | 13 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 1777-1798 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Interactions between herbal medicines and prescribed drugs: an updated systematic review | |
| P478 | volume | 69 |
| Q36460605 | A Blended Learning Course Design in Clinical Pharmacology for Post-graduate Dental Students |
| Q89861542 | A Systematic Review of the Effect of Dietary Supplements on Cognitive Performance in Healthy Young Adults and Military Personnel |
| Q35565585 | A pilot study of website information regarding aromatase inhibitors: dietary supplement interactions |
| Q38366431 | A review of nurses' knowledge, attitudes, and ability to communicate the risks and benefits of complementary and alternative medicine |
| Q21090750 | A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines |
| Q37422735 | A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors. |
| Q38209332 | A systematic review and meta-analysis of herbal medicine on chronic obstructive pulmonary diseases |
| Q38630265 | A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. |
| Q47145098 | Abuse and Misuse of Selected Dietary Supplements Among Adolescents: a Look at Poison Center Data |
| Q48215007 | Acute and chronic pretreatment with essential oil of peppermint (Mentha × piperita L., Lamiaceae) influences drug effects. |
| Q37593205 | Addition of propolis to irinotecan therapy prolongs survival in ehrlich ascites tumor-bearing mice. |
| Q38749357 | Adulterated and Counterfeit Male Enhancement Nutraceuticals and Dietary Supplements Pose a Real Threat to the Management of Erectile Dysfunction: A Global Perspective. |
| Q50094359 | Adulteration and Counterfeiting of Online Nutraceutical Formulations in the United States: Time for Intervention? |
| Q26800279 | Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs |
| Q38611443 | Adverse food-drug interactions |
| Q31051777 | Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®. |
| Q37013930 | Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors. |
| Q44590864 | Alternative therapies for asthma: are patients at risk? |
| Q39444589 | An automated system for retrieving herb-drug interaction related articles from MEDLINE. |
| Q28477174 | An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction |
| Q35919968 | An overview of the evidence and mechanisms of herb-drug interactions. |
| Q33947228 | Antibacterial activity of some selected medicinal plants of Pakistan |
| Q85005859 | Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities |
| Q64900241 | Association between complementary and alternative medicine use and prolonged time to conventional treatment among Thai cancer patients in a tertiary-care hospital. |
| Q37710055 | Behaviors of consumers, physicians and pharmacists in response to adverse events associated with dietary supplement use |
| Q49376486 | Biological activities of the red algae Galaxaura rugosa and Liagora hawaiiana butters |
| Q46369656 | Biotransformation enzyme activities and phase I metabolites analysis in Litopenaeus vannamei following intramuscular administration of T-2 toxin |
| Q33986613 | Buyer beware? Does the information provided with herbal products available over the counter enable safe use? |
| Q42126731 | Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention. |
| Q35685299 | Characterization of Changes in Global Genes Expression in the Distal Colon of Loperamide-Induced Constipation SD Rats in Response to the Laxative Effects of Liriope platyphylla |
| Q38616585 | Classification of Use Status for Dietary Supplements in Clinical Notes |
| Q38221696 | Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder |
| Q36417984 | Clinical pharmacology in sleep medicine |
| Q37968621 | Clinically significant drug interactions with newer antidepressants |
| Q50243040 | Coltsfoot as a potential cause of deep vein thrombosis and pulmonary embolism in a patient also consuming kava and blue vervain |
| Q38011807 | Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux. |
| Q35849421 | Common dietary supplements for cognitive health |
| Q35671034 | Common use of dietary supplements for bipolar disorder: a naturalistic, self-reported study |
| Q38875174 | Complementary and alternative medicine therapies for chronic pain |
| Q38202901 | Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients |
| Q45749220 | Complementary or alternative medicine in cancer care-myths and realities |
| Q35586021 | Concomitant use of dietary supplements and medicines in patients due to miscommunication with physicians in Japan |
| Q37585353 | Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study |
| Q47202565 | Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review. |
| Q43604171 | Concurrent use of drugs and supplements in a community-dwelling population aged 50 years or more: potential benefits and risks. |
| Q37640084 | Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases. |
| Q35725540 | Cytochrome P450 enzyme mediated herbal drug interactions (Part 1) |
| Q35729029 | Cytochrome P450 enzyme mediated herbal drug interactions (Part 2) |
| Q37802740 | Deleterious Effects of Reactive Metabolites |
| Q92373474 | Dietary and Supplement-Based Complementary and Alternative Medicine Use in Pediatric Autism Spectrum Disorder |
| Q36054864 | Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. |
| Q36068525 | Do your patients with bipolar disorder use dietary supplements? |
| Q46025254 | Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care. |
| Q83274402 | Drug interactions with herbal medicines |
| Q57180639 | Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs |
| Q35904433 | Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. |
| Q37314453 | Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers |
| Q34339576 | Effect of garlic on serum lipids: an updated meta-analysis |
| Q53671478 | Effect of kanglaite on rat cytochrome P450. |
| Q42074732 | Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients. |
| Q54511648 | Effectiveness and safety of combination treatment of herbal medicines and oral antihistamines for atopic dermatitis: a retrospective chart review. |
| Q58615950 | Effects of Common CYP1A2 Genotypes and other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: an Exploratory Analysis |
| Q34362562 | Effects of Flos carthami on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats |
| Q47748496 | Effects of capsicine on rat cytochrome P450 isoforms CYP1A2, CYP2C19, and CYP3A4. |
| Q43712337 | Effects of natural products on the function of human organic anion transporting polypeptide 1B1. |
| Q47782012 | Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats |
| Q37107406 | Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis |
| Q99240445 | Emerging Complementary and Integrative Therapies for Geriatric Mental Health |
| Q52677334 | Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone. |
| Q35113280 | Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies |
| Q35141015 | Ethnobotanical and antimicrobial study of some selected medicinal plants used in Khyber Pakhtunkhwa (KPK) as a potential source to cure infectious diseases |
| Q34306204 | Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review |
| Q34238039 | Evaluation of metabolism-mediated herb-drug interactions |
| Q88012905 | Flupirtine drug-induced liver injury in a patient developing acute liver failure |
| Q38695934 | Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review |
| Q42864265 | Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans |
| Q36679039 | Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic Review |
| Q38109094 | Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients |
| Q34483552 | Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients |
| Q36276879 | Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients |
| Q34279245 | Herb-drug interactions: an overview of systematic reviews |
| Q58576453 | Herbal Bioenhancers in Veterinary Phytomedicine |
| Q64235486 | Herbal Medicinal Product Use During Pregnancy and the Postnatal Period: A Systematic Review |
| Q92132099 | Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety |
| Q33786771 | Herbal and Alternative Medicine Use in Tanzanian Adults Admitted with Hypertension-Related Diseases: A Mixed-Methods Study |
| Q84030111 | Herbal medicines and forensic investigations |
| Q57273966 | Herbal tea extracts inhibit Cytochrome P450 3A4 in vitro |
| Q36916959 | Hypericum perforatum-induced hepatotoxicity with possible association with copaiba (Copaifera langsdorffii Desf):case report |
| Q34360600 | Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions |
| Q43051294 | Important drug-nutrient interactions |
| Q41534845 | In Vitro Evaluation of Reversible and Time-Dependent Inhibitory Effects of Kalanchoe crenata on CYP2C19 and CYP3A4 Activities |
| Q34774934 | Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan |
| Q36469701 | Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants |
| Q64230731 | Influences of on the Activities of CYP450 Enzymes in Rats with a Cocktail Approach |
| Q35557149 | Infrequent older adult-primary care provider discussion and documentation of dietary supplements |
| Q35162440 | Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV/AIDS patients in Africa-- implications for herb-drug interactions |
| Q49804065 | Inhibitory Influence of Panax notoginseng Saponins on Aspirin Hydrolysis in Human Intestinal Caco-2 Cells. |
| Q86056783 | Inhibitory action of Epilobium hirsutum extract and its constituent ellagic acid on drug-metabolizing enzymes |
| Q35187885 | Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. |
| Q42953779 | Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity |
| Q34512871 | Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products |
| Q38283110 | Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management |
| Q34124444 | Interactions between herbs and conventional drugs: overview of the clinical data. |
| Q38581233 | Issues and promise in clinical studies of botanicals with anticonvulsant potential |
| Q37133257 | Knowledge, attitude, and practices toward ayurvedic medicine use among allopathic resident doctors: A cross-sectional study at a tertiary care hospital in India |
| Q50052519 | Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy |
| Q38201108 | Manic psychosis associated with ginseng: a report of two cases and discussion of the literature |
| Q37637048 | Medication use by middle-aged and older participants of an exercise study: results from the Brain in Motion study. |
| Q35059110 | Microbiological profiling and the demonstration of in vitro anti-bacterial traits of the major oral herbal medicines used in Dhaka Metropolis |
| Q47219850 | Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling |
| Q26781613 | Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives |
| Q36744650 | Natural health product-drug interaction tool: A scoping review. |
| Q33946426 | Natural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research |
| Q38074992 | Nuclear receptors in herb-drug interactions. |
| Q37304704 | Optimizing chemotherapy: concomitant medication lists |
| Q33709156 | Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study |
| Q38074712 | Pharmacogenetics of clinical response to risperidone. |
| Q85829560 | Pharmacokinetic comparisons of benzoylmesaconine in rats using ultra-performance liquid chromatography-tandem mass spectrometry after administration of pure benzoylmesaconine and Wutou decoction |
| Q50094239 | Pharmacology and pharmacokinetics of imatinib in pediatric patients |
| Q86502171 | Pinelliae rhizoma, a toxic chinese herb, can significantly inhibit CYP3A activity in rats |
| Q37179352 | Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1 |
| Q39624983 | Potent inhibition of CYP1A2 by Frutinone A, an active ingredient of the broad spectrum antimicrobial herbal extract from P. fruticosa |
| Q88956486 | Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier |
| Q37803219 | Potential of St John's Wort for the treatment of depression: the economic perspective. |
| Q34700821 | Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance |
| Q38040597 | Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review. |
| Q47137566 | Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey |
| Q64938443 | Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia. |
| Q55072787 | Principles of pharmacological research of nutraceuticals. |
| Q34071450 | Provider and patient expectations for dietary supplement discussions |
| Q38047816 | Psychotropic drug-drug interactions involving P-glycoprotein |
| Q24628778 | Rainforest pharmacopeia in Madagascar provides high value for current local and prospective global uses |
| Q64100479 | Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway |
| Q88657353 | Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans? |
| Q38213152 | Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations |
| Q85823665 | Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience |
| Q41167590 | Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review |
| Q35490308 | Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity |
| Q88709362 | Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans? |
| Q28539251 | Stereoselective property of 20(S)-protopanaxadiol ocotillol type epimers affects its absorption and also the inhibition of P-glycoprotein |
| Q89944830 | Suboptimal Health, Dietary Supplementation, and Public Health Approaches to Regulatory Challenges in Dubai |
| Q55301721 | The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain. |
| Q38110713 | The classification and application of toxic Chinese materia medica. |
| Q37982110 | The effect of garlic supplements and phytochemicals on the ADMET properties of drugs |
| Q54473907 | The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations. |
| Q36324428 | The prevalence, characteristics, and factors associated with purchasing Chinese herbal medicine among adults in Taiwan |
| Q35810068 | The roles of carboxylesterase and CYP isozymes on the in vitro metabolism of T-2 toxin |
| Q38068221 | Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions |
| Q33630966 | Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression. |
| Q37943827 | Therapeutic potential of ginseng in the management of cardiovascular disorders |
| Q34614106 | Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1. |
| Q92240828 | Traditional Medicine and Its Role in the Management of Diabetes Mellitus: "Patients' and Herbalists' Perspectives" |
| Q54960358 | Traditional medicines and alternative practice in the management of prostate diseases in southern Ghana |
| Q30395449 | Traditional use of medicinal plants in the boreal forest of Canada: review and perspectives |
| Q59400990 | Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review |
| Q37387226 | Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model |
| Q37280785 | Trends in the use of oral contraceptives among adolescents and young women in Spain |
| Q91626717 | U.S. Filipino Adults' Patterns of CAM Use and Medical Pluralism: Secondary Analysis of 2012 National Health Interview Survey |
| Q36719646 | UGT concentrations in human rectal tissue after multidose, oral curcumin |
| Q38293810 | Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare |
| Q90599845 | Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine |
| Q37562491 | Unproven Therapies for Diabetes and Their Implications |
| Q33648514 | Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey. |
| Q35095883 | Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis' views on risks of negative interactions between herbal medicine and conventional drug therapies |
| Q53666242 | Use of dietary supplements for cognitive health: results of a national survey of adults in the United States. |
| Q33882005 | Use of herbal medicinal products among children and adolescents in Germany |
| Q40614867 | Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults |
| Q30420889 | Vietnamese traditional medicine from a pharmacist's perspective |
| Q37907479 | What do I tell patients about saw palmetto for benign prostatic hyperplasia? |
| Q37037596 | What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng |
| Q64053346 | What has been the impact of the Traditional Herbal Registration (THR) scheme in the UK on information provided with herbal products bought over the counter? |
Search more.